Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
9 hedge funds and large institutions have $6.59M invested in Yield10 Bioscience, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
329% more call options, than puts
Call options by funds: $30K | Put options by funds: $7K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $6.69M → $6.59M (-$98K)
25% less funds holding
Funds holding: 12 → 9 (-3)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$544K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$115K |
| 3 |
CC
Cannell & Co
New York
|
-$80.6K |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$60.5K |
| 5 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$20.2K |
YTEN Hedge Fund Activity: Q4 2015 in Review
9 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2015, worth a combined $6.59M — down 1.5% from $6.69M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of YTEN and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $20.2K. The largest seller was GMT Capital, cutting an estimated $544K.
- 9 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2015, down from 12 in Q3 2015.
- Funds reported $6.59M of Yield10 Bioscience, Inc. Common Stock stock for Q4 2015, down 1.5% quarter-over-quarter.
- 0 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2015 and 3 closed out, a net change of -3 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2015 was Geode Capital Management, an estimated $20.2K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2015 was GMT Capital, an estimated $544K sold.
Based on aggregated 13F filings for Q4 2015.